Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share By
In Silico Approaches for the Design and Optimization of Interfering Peptides Against Protein–Protein Interactions Publisher



Hashemi ZS1 ; Zarei M2 ; Fath MK3 ; Ganji M4 ; Farahani MS4 ; Afsharnouri F4 ; Pourzardosht N5, 6 ; Khalesi B7 ; Jahangiri A8 ; Rahbar MR2 ; Khalili S9
Authors

Source: Frontiers in Molecular Biosciences Published:2021


Abstract

Large contact surfaces of protein–protein interactions (PPIs) remain to be an ongoing issue in the discovery and design of small molecule modulators. Peptides are intrinsically capable of exploring larger surfaces, stable, and bioavailable, and therefore bear a high therapeutic value in the treatment of various diseases, including cancer, infectious diseases, and neurodegenerative diseases. Given these promising properties, a long way has been covered in the field of targeting PPIs via peptide design strategies. In silico tools have recently become an inevitable approach for the design and optimization of these interfering peptides. Various algorithms have been developed to scrutinize the PPI interfaces. Moreover, different databases and software tools have been created to predict the peptide structures and their interactions with target protein complexes. High-throughput screening of large peptide libraries against PPIs; “hotspot” identification; structure-based and off-structure approaches of peptide design; 3D peptide modeling; peptide optimization strategies like cyclization; and peptide binding energy evaluation are among the capabilities of in silico tools. In the present study, the most recent advances in the field of in silico approaches for the design of interfering peptides against PPIs will be reviewed. The future perspective of the field and its advantages and limitations will also be pinpointed. © Copyright © 2021 Hashemi, Zarei, Fath, Ganji, Farahani, Afsharnouri, Pourzardosht, Khalesi, Jahangiri, Rahbar and Khalili.
Other Related Docs
13. Bevacizumab Antibody Affinity Maturation to Improve Ovarian Cancer Immunotherapy: In Silico Approach, International Journal of Peptide Research and Therapeutics (2019)
16. Peptidomimetics in Cancer Targeting, Molecular Medicine (2022)